Literature DB >> 16132306

Percutaneous closure by a vascular plug of a fistula between the superior caval vein and the left atrium.

K De Groote1, H Verhaaren, B Suys, D De Wolf.   

Abstract

We report the case of a 7-year-old boy with a history of pulmonary atresia and intact septum who developed a fistula between the remnant of the ligated superior caval vein and the left atrium after bidirectional superior cavopulmonary (Glenn) anastomosis. The close proximity to the right pulmonary veins made closure by a standard occluder impossible. An Amplatzer vascular plug without rim enabled us to close the connection percutaneously without obstructing the pulmonary venous flow. The technique appeared to be easy, safe, and effective.

Entities:  

Mesh:

Year:  2005        PMID: 16132306     DOI: 10.1007/s00246-004-0850-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  3 in total

1.  Closure of a large pulmonary arteriovenous malformation using multiple Gianturco-Grifka vascular occlusion devices.

Authors:  M R Ebeid; D S Braden; C H Gaymes; J A Joransen
Journal:  Catheter Cardiovasc Interv       Date:  2000-04       Impact factor: 2.692

2.  Major intrahepatic veno-venous fistula after modified Fontan operation treated by transcatheter implantation of amplatzer septal occluder.

Authors:  M Szkutnik; J Bialkowski; P Knapik
Journal:  Cardiol Young       Date:  2001-05       Impact factor: 1.093

3.  Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures.

Authors:  J K Triedman; N D Bridges; J E Mayer; J E Lock
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

  3 in total
  1 in total

1.  Successful occlusion of a persistent left vertical vein with an Amplatzer muscular ventricular septal defect occluder.

Authors:  Albrecht Beitzke; Andreas Gamillscheg; Martin Koestenberger
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.